NEW YORK (GenomeWeb) – Quanterix said today that it has closed its initial public offering, selling more than 4.9 million shares of common stock at $15 per share, raising $73.7 million in gross proceeds. Its shares now trade on the Nasdaq under ticker symbol QTRX.

In early afternoon trading, the company's stock was up about 5 percent at $19.08 per share.

JP Morgan Securities, Leerink Partners, and Cowen were joint book-running managers for the offering, while BTIG and Evercore Group were comanagers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.